These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 8574502)

  • 1. Aminoglycoside pharmacokinetics and -dynamics: a nonlinear approach.
    Czock D; Giehl M
    Int J Clin Pharmacol Ther; 1995 Oct; 33(10):537-9. PubMed ID: 8574502
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics of amikacin in plasma and selected body fluids of healthy horses after a single intravenous dose.
    Pinto N; Schumacher J; Taintor J; Degraves F; Duran S; Boothe D
    Equine Vet J; 2011 Jan; 43(1):112-6. PubMed ID: 21143642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Application of artificial neural networks to clinical pharmacology.
    Brier ME; Aronoff GR
    Int J Clin Pharmacol Ther; 1996 Nov; 34(11):510-4. PubMed ID: 8937935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of population pharmacokinetic models for amikacin dosage individualization in critically ill patients.
    Mar Fernández de Gatta MD; Victoria Calvo M; Ardanuy R; Domínguez-Gil A; Lanao JM; Moreno SR
    J Pharm Pharmacol; 2009 Jun; 61(6):759-66. PubMed ID: 19505366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Experience with a once-daily dosing program of aminoglycosides in critically ill patients.
    Buijk SE; Mouton JW; Gyssens IC; Verbrugh HA; Bruining HA
    Intensive Care Med; 2002 Jul; 28(7):936-42. PubMed ID: 12122533
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nephrotoxicity of aminoglycosides. Effects on pharmacokinetics and prevention.
    Brogard JM; Comte F; Spach MO
    Contrib Nephrol; 1984; 42():182-95. PubMed ID: 6398194
    [No Abstract]   [Full Text] [Related]  

  • 7. [Use of aminoglycoside antibiotic gentamycin in extremely premature infants--administration schedule and suggested dosage based on pharmacokinetic studies in plasma].
    Slŭncheva B; Emilova Z; Vakrilova L; Pramatarova T; Popivanova A; Svinarov D
    Akush Ginekol (Sofiia); 2006; 45(3):30-3. PubMed ID: 16889185
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modification of Diet in Renal Disease and modified Cockcroft-Gault formulas in predicting aminoglycoside elimination.
    Bookstaver PB; Johnson JW; McCoy TP; Stewart D; Williamson JC
    Ann Pharmacother; 2008 Dec; 42(12):1758-65. PubMed ID: 19047358
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Amikacin in neonates: dosing recommendations should be based on both pharmacokinetics and dynamics.
    Allegaert K; Sherwin CM
    Singapore Med J; 2010 Jan; 51(1):88-9. PubMed ID: 20200782
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacokinetic basis for the use of extended interval dosage regimens of gentamicin in neonates.
    Lanao JM; Calvo MV; Mesa JA; Martín-Suárez A; Carbajosa MT; Miguelez F; Domínguez-Gil A
    J Antimicrob Chemother; 2004 Jul; 54(1):193-8. PubMed ID: 15150171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Amikacin pharmacokinetics and the effects of ambient temperature on the dosage regimen in ball pythons (Python regius).
    Johnson JH; Jensen JM; Brumbaugh GW; Boothe DM
    J Zoo Wildl Med; 1997 Mar; 28(1):80-8. PubMed ID: 9226620
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Aminoglycoside dosing in burn patients using first-dose pharmacokinetics.
    Hollingsed TC; Harper DJ; Jennings JP; Morris SE; Saffle JR
    J Trauma; 1993 Sep; 35(3):394-8. PubMed ID: 8371297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Aminoglycoside pharmacokinetics in neonates: the need to search for covariates of variability in addition to case descriptions.
    Allegaert K
    Acta Paediatr; 2009 Oct; 98(10):1546; author reply 1546-7. PubMed ID: 19659582
    [No Abstract]   [Full Text] [Related]  

  • 14. "Once-daily" versus "extended-interval" administration of aminoglycosides in neonates: need for standard terminology.
    Miller MM; Burton ME; Johnson PN; Miller JL
    Am J Health Syst Pharm; 2014 Dec; 71(24):2108-9. PubMed ID: 25465576
    [No Abstract]   [Full Text] [Related]  

  • 15. In vivo simulation of human pharmacokinetics in the rabbit.
    Bugnon D; Potel G; Caillon J; Baron D; Drugeon HB; Feigel P; Kergueris MF
    Bull Math Biol; 1998 May; 60(3):545-67. PubMed ID: 9608855
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetics and biodistribution of amikacin encapsulated in carrier erythrocytes.
    Gutiérrez Millán C; Zarzuelo Castañeda A; González López F; Sayalero Marinero ML; Lanao JM
    J Antimicrob Chemother; 2008 Feb; 61(2):375-81. PubMed ID: 18096557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of fever on pharmacokinetics and dosage regimen of intramuscularly administered amikacin in goats.
    Agrawal AK; Singh SD; Jayachandran C
    J Vet Sci; 2001 Aug; 2(2):91-6. PubMed ID: 14614277
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The immunomodulating action of aminoglycoside antibiotics via different administration technics].
    Siplivaia LE; Shetsova EM; Lazarev AI; Prokopenko LG
    Antibiot Khimioter; 1999; 44(2):29-32. PubMed ID: 10202555
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparative pharmacokinetics of amikacin following a single intramuscular or subcutaneous administration in goats (Capra hircus).
    Uppal RP; Verma SP; Verma V; Garg SK
    Vet Res; 1997; 28(6):565-70. PubMed ID: 9428150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between pharmacokinetic half-life and pharmacodynamic half-life in effect-time modeling.
    Keller F; Czock D; Zellner D; Giehl M
    Int J Clin Pharmacol Ther; 1998 Mar; 36(3):168-75. PubMed ID: 9562234
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.